Publications by authors named "Matthew Folstad"

Claim this Profile
M
Maintenance low-dose fixed duration lenalidomide and rituximab following bendamustine and rituximab induction in previously untreated chronic lymphocytic leukemia and small lymphocytic lymphoma.
Julie E Chang, Tuo Wang, KyungMann Kim, Matthew Folstad, Mariah Endres

Leuk Lymphoma· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Older patients with primary central nervous system lymphoma: Survival and prognostication across 20 U.S. cancer centers.
Kevin A David, Suchitra Sundaram, Seo-Hyun Kim, Ryan Vaca, Yong Lin, Matthew Folstad

Am J Hematol· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
EBV-positive PCNSL in older patients: incidence, characteristics, tumor pathology, and outcomes across a large multicenter cohort.
Prashasti Agrawal, Kevin A David, Zhengming Chen, Suchitra Sundaram, Seo-Hyun Kim, Matthew Folstad

Leuk Lymphoma· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Case of Isolated Myeloid Sarcoma Associated With Germline T790M Variant: The Importance of Recognizing Potential Germline Variants on Somatic Tumor Sequencing Panels.
Margaret Walker, Matthew Folstad, Kelcy Smith-Simmer, Erica Reinig, Kalyan Nadiminti

J Hematol· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Crystal structures of 2,6-bis-[(1H-1,2,4-triazol-1-yl)meth-yl]pyridine and 1,1-[pyridine-2,6-diylbis(methyl-ene)]bis-(4-methyl-1H-1,2,4-triazol-4-ium) iodide triiodide.
Marites A Guino-O, Matthew J Folstad, Daron E Janzen

Acta Crystallogr E Crystallogr Commun· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis